Programming and Regulation of Metabolic Homeostasis by HDAC11

被引:79
|
作者
Sun, Lei [1 ,2 ]
de Evsikova, Caralina Marin [3 ]
Bian, Ka [1 ,2 ]
Achille, Alexandra [4 ]
Telles, Elphine [1 ]
Pei, Huadong [1 ,2 ]
Seto, Edward [1 ,2 ]
机构
[1] George Washington Univ, Canc Ctr, Washington, DC 20052 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA
[3] Morsani Coll Med, Dept Mol Med, Tampa, FL USA
[4] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33612 USA
来源
EBIOMEDICINE | 2018年 / 33卷
关键词
HDAC11; Obesity; Metabolic syndrome; Hepatic steatosis; UCP1; CPT1; Adiponectin; BROWN ADIPOSE-TISSUE; FATTY-ACID SYNTHESIS; DIET-INDUCED OBESITY; HISTONE DEACETYLASES; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; LIVER; EXPRESSION; MICE; INHIBITOR;
D O I
10.1016/j.ebiom.2018.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Histone deacetylases (HDACs) are enzymes that regulate protein functions by catalyzing the removal of acetyl and acyl groups from lysine residues. They play pivotal roles in governing cell behaviors and are indispensable in numerous biological processes. HDAC11. the last identified and sole member of class IV HDACs, was reported over a decade ago. However, its physiological function remains poorly understood. Here, we report that HDACI 1 knockout mice are resistant to high-fat diet-induced obesity and metabolic syndrome, suggesting that HDAC11 functions as a crucial metabolic regulator. Depletion of HDAC11 significantly enhanced insulin sensitivity and glucose tolerance, attenuated hypercholesterolemia, and decreased hepatosteatosis and liver damage. Mechanistically, HDAC11 deficiency boosts energy expenditure through promoting thermogenic capacity, which attributes to the elevation of uncoupling protein 1 (UCP1) expression and activity in brown adipose tissue. Moreover, loss of HDACI 1 activates the adiponectin-AdipoR-AMPK pathway in the liver, which may contribute to a reversal in hepatosteatosis. Overall, our findings distinguish HDAC11 as a novel regulator of obesity, with potentially important implications for obesity-related disease treatment. (C) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [1] HDAC11, an emerging therapeutic target for metabolic disorders
    Chen, Huizhen
    Xie, Chunguang
    Chen, Qiu
    Zhuang, Shougang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [2] Garcinol Is an HDAC11 Inhibitor
    Son, Se In
    Su, Dan
    Ho, Thanh Tu
    Lin, Hening
    ACS CHEMICAL BIOLOGY, 2020, 15 (11) : 2866 - 2871
  • [3] Regulation of HDAC11 gene expression in early myogenic differentiation
    Li, Qiao
    Mach, Yan Z.
    Hamed, Munerah
    Khilji, Saadia
    Chen, Jihong
    PEERJ, 2023, 11
  • [4] Programming and regulation of metabolic homeostasis
    Wilson, David F.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2015, 308 (06): : E506 - E517
  • [5] Catalytic activity of HDAC8 and HDAC11
    Joseph, Caleb Georgesson
    Fuchter, Matthew
    Fierke, Carol
    FASEB JOURNAL, 2010, 24
  • [6] HDAC11: a rising star in epigenetics
    Liu, Shan-Shan
    Wu, Fei
    Jin, Yue-Mei
    Chang, Wei-Qin
    Xu, Tian-Min
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [7] Catalytic Activity of HDAC11 and HDAC8
    Joseph, Caleb G.
    FASEB JOURNAL, 2011, 25
  • [8] The role of HDAC11 in obesity-related metabolic disorders: A critical review
    Yang, Hong
    Chen, Lingling
    Sun, Qian
    Yao, Fangyao
    Muhammad, Saeed
    Sun, Chao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5582 - 5591
  • [9] Elucidating the enzymatic activity of HDAC11
    Yruela, Carlos Moreno
    Galleano, Iacopo
    Madsen, Andreas
    Olsen, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [10] Role of HDAC11 in Myogenic Differentiation
    Kim, Hyunmi
    Oh, Kyoung-Jin
    DIABETES, 2017, 66 : LB79 - LB79